| Evaluation of the CONVIVO System (NCT05139277) | Dartmouth-Hitchcock Medical Center | 2022-06-28 |
| Intravenous Tranexamic Acid Reducing Intraoperative Blood Loss in Huge Meningiomas Resection (NCT05230381) | Beijing Tiantan Hospital | 2022-06-15 |
| Intraoperative Laser Speckle Contrast Imaging to Assess Blood Flow During Neurosurgery (NCT05028400) | Insel Gruppe AG, University Hospital Bern | 2022-02-01 |
| Tranexamic Acid Reduce Blood Loss in Meningioma Resection (NCT04386642) | Chiang Mai University | 2021-09-01 |
| Androcur® (Cyproterone Acetate) and Meningioma Development: a Genotype-environment Association Study (NCT04372095) | Assistance Publique - Hôpitaux de Paris | 2021-07-06 |
| Treatment of Recurrent or Progressive Meningiomas With the Radiolabelled Somatostatin Antagonist 177Lu-satoreotide (NCT04997317) | University Hospital, Basel, Switzerland | 2021-04-21 |
| PREselection of Patients at Risk for COgnitive DEcline After Radiotherapy Using Advanced MRI (NCT04638478) | Maastricht Radiation Oncology | 2021-04-08 |
| Use of Non-invasive Optical Analysis in Neurosurgery (NCT04712214) | Imperial College London | 2021-03-28 |
| Predictive Factors for Survival in Aggressive Meningiomas (NCT05793034) | Fondazione Policlinico Universitario Agostino Gemelli IRCCS | 2021-01-07 |
| The Safety of Intravenous Tranexamic Acid in Patients Undergoing Supratentorial Meningiomas Resection (NCT04595786) | Beijing Tiantan Hospital | 2020-10-30 |
| Gleolan for Visualization of Newly Diagnosed or Recurrent Meningioma (NCT04305470) | NX Development Corp | 2020-10-28 |
| Research of Biomarkers of Response to Proton Beam Therapy in Pediatric and Adult Patients. (NCT04367779) | Centre Leon Berard | 2020-09-24 |
| Innovative Trial for Understanding the Impact of Targeted Therapies in NF2-Related Schwannomatosis (INTUITT-NF2) (NCT04374305) | Scott R. Plotkin, MD, PhD | 2020-06-20 |
| MEningioma Detection Using Non Contrast MRI TecHniquEs (NCT04113408) | Fondation Ophtalmologique Adolphe de Rothschild | 2020-06-12 |
| Establishment and Characterization of Meningioma Patient-derived Organoids (NCT04478877) | Chinese University of Hong Kong | 2020-05-23 |
| MiDura-Study (Neuro-Patch in Duraplasty) (NCT04189172) | Aesculap AG | 2020-02-06 |
| Concordance and Accuracy of MRI in the Detection of Meningiomas: Optimizing Sequences With Low Doses of Gadolinium (NCT04113395) | Fondation Ophtalmologique Adolphe de Rothschild | 2019-12-23 |
| Cognitive Status After Removal of Skull Base Meningioma (NCT04635657) | Ohio State University | 2019-12-10 |
| Closed vs. Open Face Masks for Cranial Radiotherapy (NCT04079595) | University of Zurich | 2019-12-09 |
| Combination of Alpelisib and Trametinib in Progressive Refractory Meningiomas (NCT03631953) | Assistance Publique Hopitaux De Marseille | 2019-09-30 |
| 68-Ga DOTATATE PET/MRI in the Diagnosis and Management of Somatostatin Receptor Positive CNS Tumors. (NCT04081701) | Weill Medical College of Cornell University | 2019-09-04 |
| Long-Term Longitudinal QoL in Patients Undergoing EEA (NCT04087902) | Ohio State University | 2019-07-16 |
| Phase II Study of 177Lu-DOTATATE Radionuclide in Adults With Progressive or High-risk Meningioma (NCT03971461) | NYU Langone Health | 2019-05-15 |
| Meningiomas and Treatment With CYPROTERONE ACETATE or Progestin (NCT04109404) | University Hospital, Brest | 2019-02-25 |
| Effects of Scalp Nerve Block With Ropivacaine on Postoperative Recovery Quality (NCT03648034) | RenJi Hospital | 2018-09-18 |
| Magnesium and Intraoperative Blood Loss in Meningioma Surgery (NCT03558516) | Mahidol University | 2018-08-01 |
| DOTATOC PET/CT for Imaging NET Patients (NCT03583528) | British Columbia Cancer Agency | 2018-07-11 |
| Peptide Receptor Radionuclide Therapy Administered to Participants With Meningioma With 67Cu-SARTATE™ (NCT03936426) | Clarity Pharmaceuticals Ltd | 2018-07-09 |
| Neoadjuvant Avelumab and Hypofractionated Proton Radiation Therapy Followed by Surgery for Recurrent Radiation-refractory Meningioma (NCT03267836) | Washington University School of Medicine | 2018-01-10 |
| Proton Therapy Research Infrastructure- ProTRAIT- Neuro-oncology (NCT04648462) | Maastricht Radiation Oncology | 2018-01-01 |
| Vistusertib (AZD2014) For Recurrent Grade II-III Meningiomas (NCT03071874) | Massachusetts General Hospital | 2017-10-17 |
| Liquid Biopsy Evaluation and Repository Development at Princess Margaret (NCT03702309) | University Health Network, Toronto | 2017-08-03 |
| 68Ga-DOTA-TOC PET/CT in Imaging Participants With Neuroendocrine Tumors (NCT03001349) | M.D. Anderson Cancer Center | 2017-05-16 |
| Trial of Selumetinib in Patients With Neurofibromatosis Type II Related Tumors (NCT03095248) | Children's Hospital Medical Center, Cincinnati | 2017-05-08 |
| Dosimetry Guided PRRT With 90Y-DOTATOC (NCT03013387) | Sue O'Dorisio | 2017-01-01 |
| Ribociclib (LEE011) in Preoperative Glioma and Meningioma Patients (NCT02933736) | Nader Sanai | 2016-10-17 |
| AZD2014 In NF2 Patients With Progressive or Symptomatic Meningiomas (NCT02831257) | Massachusetts General Hospital | 2016-08-31 |
| A Trial of Increased Dose Intensity Modulated Proton Therapy (IMPT) for High-Grade Meningiomas (NCT02693990) | Massachusetts General Hospital | 2016-02-01 |
| Exploratory Evaluation of AR-42 Histone Deacetylase Inhibitor in the Treatment of Vestibular Schwannoma and Meningioma (NCT02282917) | Massachusetts Eye and Ear Infirmary | 2015-12-01 |
| Longitudinal Prospective Study of Neurocognition & Neuroimaging in Primary BT Patients (NCT05576103) | Jona Hattangadi-Gluth | 2015-01-01 |
| Information Presentation Formats (NCT02267928) | Carnegie Mellon University | 2014-10-01 |
| T Cell Receptor Immunotherapy Targeting NY-ESO-1 for Patients With NY-ESO-1 Expressing Cancer (NCT01967823) | National Cancer Institute (NCI) | 2013-10-24 |
| A Comparative Study of Prophylactic Anticoagulation in Meningioma Surgery (NCT01941602) | St. Olavs Hospital | 2013-08-01 |
| Automated Segmentation and Volumetry for Meningioma Using Deep Learning (NCT05093751) | Seoul National University Hospital | 2013-03-23 |
| Carbon Ion Radiotherapy for Atypical Meningiomas (NCT01166321) | University Hospital Heidelberg | 2012-06-01 |
| Proton Radiation For Meningiomas and Hemangiopericytomas (NCT01117844) | Abramson Cancer Center at Penn Medicine | 2010-02-04 |
| Vascular Endothelial Growth Factor (VEGF) Levels in Brain Tumor Patients (NCT00985036) | Marquette General Health System | 2009-09-01 |
| Monthly SOM230C for Recurrent or Progressive Meningioma (NCT00859040) | Patrick Y. Wen, MD | 2009-03-01 |
| Stereotactic Body Radiotherapy for Spine Tumors (NCT01347307) | Mercy Research | 2008-09-01 |
| Evaluation of Brain Functional Changes With 18F-FDG PET and Cognitive Processes After Brain Radiotherapy for Cavernous Sinus Meningiomas and Non-secreting ACTH Adenomas (NCT06180226) | IRCCS San Raffaele | 2008-04-21 |
| Combination of Hydroxyurea and Verapamil for Refractory Meningiomas (NCT00706810) | University of Utah | 2007-12-01 |
| Phase II Trial of Sunitinib (SU011248) in Patients With Recurrent or Inoperable Meningioma (NCT00589784) | Memorial Sloan Kettering Cancer Center | 2007-10-01 |
| SeOuL cOhort of Brain Tumor MONitoring Study (SOLOMON) (NCT05254197) | Seoul National University Hospital | 2001-01-01 |
| Correlation Between Expression of Hormonal Receptors, Clinical Data, and Methylation Profile in Meningiomas (MethylRH-M) (NCT06278103) | Central Hospital, Nancy, France | 2000-01-01 |
| Antineoplaston Therapy in Treating Patients With Meningioma (NCT00003483) | Burzynski Research Institute | 1998-06-01 |
| S9005 Mifepristone in Meningioma (NCT03015701) | SWOG Cancer Research Network | 1992-08-01 |
| The Etiology and Progression of Brain Tumors (NCT01811524) | Tampere University Hospital | 1983-09-01 |
| ITM11 Expanded Access Program (NCT07497984) | ITM Solucin GmbH | |